SYNH Stock Recent News

Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations to biopharmaceutical customers.

Syneos Health's (SYNH) new partnership will develop an advanced commercialization model to serve healthcare professionals and patients in the best possible way in today's changing environment.

MORRISVILLE, N.C., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 10:30 a.m. EST. The Company will not be hosting investor meetings.

Syneos Health (SYNH) experiences delays in large pharma award decisions, with net awards being impacted by greater-than-normal delays.

Syneos Health, Inc. (NASDAQ:SYNH ) Q3 2022 Earnings Conference Call November 4, 2022 8:00 AM ET Company Participants Ronnie Speight - Senior Vice President, Investor Relations Michelle Keefe - Chief Executive Officer Jason Meggs - Chief Financial Officer Michael Brooks - Chief Operating Officer Conference Call Participants Patrick Donnelly - Citi Dave Windley - Jefferies Luke Sergott - Barclays Sandy Draper - Guggenheim Securities Elizabeth Anderson - Evercore ISI Justin Bowers - Deutsche Bank Eric Coldwell - Baird Max Smock - William Blair Casey Woodring - JP Morgan John Sourbeer - UBS Operator Good morning and welcome to the Syneos Health Third Quarter 2022 Earnings Conference Call. At this time all participants are in listen-only mode.

MORRISVILLE, N.C., Oct. 21, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2022 financial results on Friday, November 4, 2022, prior to its earnings call at 8:00 a.m. ET.

Investors are optimistic about Syneos Health's (SYNH) better-than-expected earnings and robust segmental results.

MORRISVILLE, N.C, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Michelle Keefe and Chief Financial Officer Jason Meggs are scheduled to present at the 2022 Baird Global Healthcare Conference on September 13, 2022, at 2:00 p.m. ET.

Syneos Health (SYNH) posts better-than-expected earnings in the second quarter and robust results across the Clinical Solutions and Commercial Solutions businesses.

Syneos Health, Inc. (NASDAQ:SYNH ) Q2 2022 Earnings Conference Call August 2, 2022 9:00 AM ET Company Representatives Michelle Keefe - Chief Executive Officer Jason Meggs - Chief Financial Officer Michael Brooks - Chief Operating Officer Ronnie Speight - Senior Vice President, Investor Relations Conference Call Participants Luke Sergott - Barclays Dave Windley - Jefferies Patrick Donnelly - Citi Christine Rains - William Blair Casey Woodring - JP Morgan Sandy Draper - Guggenheim Elizabeth Anderson - Evercore Eric Coldwell - Baird Ann Hynes - Mizuho Operator Good morning and welcome to the Syneos Health, Second Quarter 2022 Earnings Conference Call. At this time all participants are in listen-only mode.